Researchers gain new insights into how the isotope astatine-211 interacts with resins commonly used to purify the isotope for therapeutic use Targeted Alpha Therapy (TAT) is one of the most powerful ...

Radiopharmaceutical experts and researchers to gather June 19-20 in New Orleans NEW ORLEANS, May 12, 2025 (GLOBE NEWSWIRE) -- The first-ever U.S.-based meeting of the World Astatine Community will ...

Concept of the automated system for remote dissolution of the irradiated bismuth target and astatine recovery in nitric acid media. Astatine-211 (At-211) is one of a handful of promising alpha ...

Oncodesign Services extends collaboration with GIP ARRONAX to strengthen astatine-211 supply for targeted alpha radiotherapy: Dijon, France Tuesday, April 14, 2026, 14:00 Hrs [IST ...

A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a first-in-human study, ...

GOTHENBURG, Sweden and LONDON, Jan. 23, 2026 /PRNewswire/ -- Atley Solutions and Perceptive Discovery today announced the sale of two Atley C100 modules to Perceptive Discovery, marking the first step ...

CHESTER SPRINGS, PA — Curadh MTR Inc. and Alpha Fusion, Inc. are set to showcase advances in cancer treatment using Astatine-211 (At-211) radiopharmaceuticals at the upcoming 4th Targeted ...

dGenThera, Inc., a radiopharmaceutical company, announces partnership with Alpha Nuclide Co, LTD to secure scalable supply of Astatine-211 (At-211) in China. DURHAM ...

Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF. Visit NAP.edu/10766 to get more information about this ...

DURHAM, NC, UNITED STATES, March 10, 2026 /EINPresswire.com/ — [DURHAM, NC, USA and JIAXING, CHINA] dGenThera, Inc. (“dGenThera”), a radiopharmaceutical company ...